FDA
Teva Recalls 580,000 Blood Pressure Pills Over Cancer Risk
100% left coverage4 sources
FDA
First 100 Days
See how you scored in predicting Trump's first 100 days
Latest News
FDA, European Union
RemeGen Shares Surge 567% YTD After Breakthrough Clinical Results Amid High Valuation Risks
100% left coverage1 source
FDA, European Union
RemeGen Shares Surge 567% YTD After Breakthrough Clinical Results Amid High Valuation Risks
100% left coverage1 source
FDA
FDA Expands Cinnamon Lead Recalls to 18 Brands
100% left coverage4 sources
FDA
FDA Expands Cinnamon Lead Recalls to 18 Brands
100% left coverage4 sources
FDA
Teva Recalls 580,000 Blood Pressure Pills Over Cancer Risk
100% left coverage4 sources
FDA
Teva Recalls 580,000 Blood Pressure Pills Over Cancer Risk
100% left coverage4 sources
FDA, Markets
FDA Places Clinical Hold on Intellia's Late-Stage CRISPR Trials After Severe Adverse Event
100% left coverage1 source
FDA, Markets
FDA Places Clinical Hold on Intellia's Late-Stage CRISPR Trials After Severe Adverse Event
100% left coverage1 source
FDA
Irish Aldi Lidl Recall Allergy Risk Halloween Treats Peanuts Eggs
100% left coverage1 source
FDA
Irish Aldi Lidl Recall Allergy Risk Halloween Treats Peanuts Eggs
100% left coverage1 source
FDA
FDA Plans Streamlined Biosimilar Approval To Accelerate Access
50% center coverage2 sources
FDA
FDA Plans Streamlined Biosimilar Approval To Accelerate Access
50% center coverage2 sources
FDA
FDA Rejects Regeneron's Eylea HD Due to Manufacturing Issues, New Filing Planned
100% left coverage1 source
FDA
FDA Rejects Regeneron's Eylea HD Due to Manufacturing Issues, New Filing Planned
100% left coverage1 source
First 100 Days
See how you scored in predicting Trump's first 100 days
Most Reported By
News from FDA
News from FDA